Trial Type
Follow-Up Treatment (Metastatic Disease)
Description for experts
Prospective, randomized, single-center study on the impact of intensive nutritional counseling on quality of life in patients with metastatic breast cancer under CDK4/6 or mTOR inhibition
Description for laymen
Prospective, randomized, single-center study on the impact of intensive nutritional counseling on quality of life in patients with metastatic breast cancer under CDK4/6 or mTOR inhibition
JSON Data
{
"short_title": "Nutrition",
"data_mode": "900",
"data_mode_number": "000002082",
"official_title": "Prospektive, randomisierte, monozentrische Studie zum Einfluss einer intensiven Ern\u00c3\u00a4hrungsberatung auf die Lebensqualit\u00c3\u00a4t bei Patienten mit metastasiertem Brustkrebs unter CDK4/6- oder mTOR-Inhibition",
"accrual_state": "running",
"therapeutic_value": "therapeutic",
"therapieansatz_value": "palliativ",
"therapieintervention_value": "not_applicable",
"therapielinie_value": "second",
"ctgov_number": null,
"eudract_number": null,
"general_contact_email": "studiensekretariat.gyn@ukdd.de",
"general_contact_phone": "+49 351-4584202",
"hauptpruefer_dd_name": "Prof. Dr. med. Pauline Wimberger",
"description_laie_de": "Prospektive, randomisierte, monozentrische Studie zum Einfluss einer intensiven Ern\u00e4hrungsberatung auf die Lebensqualit\u00e4t bei Patienten mit metastasiertem Brustkrebs unter CDK4/6- oder mTOR-Inhibition",
"description_laie_en": "Prospective, randomized, single-center study on the impact of intensive nutritional counseling on quality of life in patients with metastatic breast cancer under CDK4/6 or mTOR inhibition",
"description_expert_de": "Prospektive, randomisierte, monozentrische Studie zum Einfluss einer intensiven Ern\u00e4hrungsberatung auf die Lebensqualit\u00e4t bei Patienten mit metastasiertem Brustkrebs unter CDK4/6- oder mTOR-Inhibition",
"description_expert_en": "Prospective, randomized, single-center study on the impact of intensive nutritional counseling on quality of life in patients with metastatic breast cancer under CDK4/6 or mTOR inhibition",
"rechtsgrundlage_value": "BO",
"phase_amg_value": null,
"main_cat_id": 3,
"sub_cat_id": 16
}